Advertisement

Optimal Nutrition in Hemodialysis Patients

  • T. Alp Ikizler
    Correspondence
    Address correspondence to T. Alp Ikizler, MD, Vanderbilt University Medical Center, Division of Nephrology, 1161 21st Avenue South, S-3223 Medical Center North, Nashville, TN 37232-2372.
    Affiliations
    Department of Medicine, Division of Nephrology, Vanderbilt University School of Medicine, Nashville, TN
    Search for articles by this author
      Protein-energy wasting (PEW) is highly prevalent in patients undergoing maintenance hemodialysis (MHD). It is important to note that there is a robust association between the extent of PEW and the risk of hospitalization and death in these patients, regardless of the nutritional marker used. The multiple etiologies of PEW in advanced kidney disease are still being elucidated. Apart from the multiple mechanisms that might lead to PEW, it appears that the common pathway for all of the derangements is related to exaggerated protein degradation along with decreased protein synthesis. The hemodialysis procedure per se is an important contributor to this process. Metabolic and hormonal derangements such as acidosis, inflammation, and resistance to anabolic properties of insulin resistance and growth hormone are all implicated for the development of PEW in MHD patients. Appropriate management of MHD patients at risk for PEW requires a comprehensive combination of strategies to diminish protein and energy depletion and to institute therapies that will avoid further losses. The mainstay of nutritional treatment in MHD patients is provision of an adequate amount of protein and energy, using oral supplementation as needed. Intradialytic parenteral nutrition should be attempted in patients who cannot efficiently use the gastrointestinal tract. Other anabolic strategies such as exercise, anabolic hormones, anti-inflammatory therapies, and appetite stimulants can be considered as complementary therapies in suitable patients.

      Key Words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Advances in Chronic Kidney Disease
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Fouque D.
        • Kalantar-Zadeh K.
        • Kopple J.
        • et al.
        A proposed nomenclature and diagnostic criteria for protein-energy wasting in acute and chronic kidney disease.
        Kidney Int. 2008; 73: 391-398
        • Sardesai V.M.
        Fundamentals of Nutrition.
        in: Dekker M. Introduction to Clinical Nutrition. Sardesai V.M, New York, NY1998: 1-13
        • Ikizler T.A.
        • Hakim R.M.
        Nutrition in end-stage renal disease.
        Kidney Int. 1996; 50: 343-357
        • Jeejeebhoy K.N.
        Nutritional assessment.
        Nutrition. 2000; 16: 585-590
      1. Identifying patients at risk: ADA's definitions for nutrition screening and nutrition assessment. Council on Practice (COP) Quality Management Committee.
        J Am Diet Assoc. 1994; 94: 838-839
        • Pupim L.
        • Martin C.J.
        • Ikizler T.A.
        Assessment of Protein-Energy Nutritional Status.
        in: Kopple J.D. Massry S.G. Nutritional Management of Renal Disease. 2nd ed. Lippincott Williams & Wilkins, Philadelphia, PA2004: 223-240
        • Pifer T.B.
        • McCullough K.P.
        • Port F.K.
        • et al.
        Mortality risk in hemodialysis patients and changes in nutritional indicators: DOPPS.
        Kidney Int. 2002; 62: 2238-2245
        • Lopes A.A.
        • Bragg-Gresham J.L.
        • Elder S.J.
        • et al.
        Independent and joint associations of nutritional status indicators with mortality risk among chronic hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study (DOPPS).
        J Ren Nutr. 2010; 20: 224-234
        • Cano N.J.
        • Roth H.
        • Aparicio M.
        • et al.
        Malnutrition in hemodialysis diabetic patients: evaluation and prognostic influence.
        Kidney Int. 2002; 62: 593-601
        • Anderson C.F.
        • Wochos D.N.
        The utility of serum albumin values in the nutritional assessment of hospitalized patients.
        Mayo Clin Proc. 1982; 57: 181-184
        • Reinhardt G.F.
        • Myscofski J.W.
        • Wilkens D.B.
        • Dobrin P.B.
        • Mangan Jr., J.E.
        • Stannard R.T.
        Incidence and mortality of hypoalbuminemic patients in hospitalized veterans.
        JPEN J Parenter Enteral Nutr. 1980; 4: 357-359
        • Apelgren K.N.
        • Rombeau J.L.
        • Twomey P.L.
        • Miller R.A.
        Comparison of nutritional indices and outcome in critically ill patients.
        Crit Care Med. 1982; 10: 305-307
        • Kaw M.
        • Sekas G.
        Long-term follow-up of consequences of percutaneous endoscopic gastrostomy (PEG) tubes in nursing home patients.
        Dig Dis Sci. 1994; 39: 738-743
        • Ikizler T.A.
        The use and misuse of serum albumin as a nutritional marker in kidney disease.
        Clin J Am Soc Nephrol. 2012; 7: 1375-1377
        • Combe C.
        • McCullough K.P.
        • Asano Y.
        • Ginsberg N.
        • Maroni B.J.
        • Pifer T.B.
        Kidney Disease Outcomes Quality Initiative (K/DOQI) and the Dialysis Outcomes and Practice Patterns Study (DOPPS): nutrition guidelines, indicators, and practices.
        Am J Kidney Dis. 2004; 44: 39-46
        • Kalantar-Zadeh K.
        • Cano N.J.
        • Budde K.
        • et al.
        Diets and enteral supplements for improving outcomes in chronic kidney disease.
        Nat Rev Nephrol. 2011; 7: 369-384
        • Kalantar-Zadeh K.
        • Kuwae N.
        • Wu D.Y.
        • et al.
        Associations of body fat and its changes over time with quality of life and prospective mortality in hemodialysis patients.
        Am J Clin Nutr. 2006; 83: 202-210
        • Mehrotra R.
        • Duong U.
        • Jiwakanon S.
        • et al.
        Serum albumin as a predictor of mortality in peritoneal dialysis: comparisons with hemodialysis.
        Am J Kidney Dis. 2011; 58: 418-428
        • Noori N.
        • Kovesdy C.P.
        • Dukkipati R.
        • et al.
        Survival predictability of lean and fat mass in men and women undergoing maintenance hemodialysis.
        Am J Clin Nutr. 2010; 92: 1060-1070
        • Cano N.J.
        • Fouque D.
        • Roth H.
        • et al.
        Intradialytic parenteral nutrition does not improve survival in malnourished hemodialysis patients: a 2-year multicenter, prospective, randomized study.
        J Am Soc Nephrol. 2007; 18: 2583-2591
        • Lacson Jr., E.
        • Wang W.
        • Zebrowski B.
        • Wingard R.
        • Hakim R.M.
        Outcomes associated with intradialytic oral nutritional supplements in patients undergoing maintenance hemodialysis: a quality improvement report.
        Am J Kidney Dis. 2012; 60: 591-600
        • Cheu C.
        • Pearson J.
        • Dahlerus C.
        • et al.
        Association between oral nutritional supplementation and clinical outcomes among patients with ESRD.
        Clin J Am Soc Nephrol. 2012; 7: 1897-1905
        • Bossola M.
        • Tazza L.
        • Giungi S.
        • Luciani G.
        Anorexia in hemodialysis patients: an update.
        Kidney Int. 2006; 70: 417-422
        • Carrero J.J.
        Identification of patients with eating disorders: clinical and biochemical signs of appetite loss in dialysis patients.
        J Ren Nutr. 2009; 19: 10-15
        • Carrero J.J.
        Mechanisms of altered regulation of food intake in chronic kidney disease.
        J Ren Nutr. 2011; 21: 7-11
        • Chung S.H.
        • Carrero J.J.
        • Lindholm B.
        Causes of poor appetite in patients on peritoneal dialysis.
        J Ren Nutr. 2011; 21: 12-15
        • Lim V.S.
        • Kopple J.D.
        Protein metabolism in patients with chronic renal failure: role of uremia and dialysis.
        Kidney Int. 2000; 58: 1-10
        • Raj D.S.
        • Adeniyi O.
        • Dominic E.A.
        • et al.
        Amino acid repletion does not decrease muscle protein catabolism during hemodialysis.
        Am J Physiol Endocrinol Metab. 2007; 292: E1534-E1542
        • Ikizler T.A.
        • Greene J.H.
        • Wingard R.L.
        • Hakim R.M.
        Nitrogen balance in hospitalized chronic hemodialysis patients.
        Kidney Int Suppl. 1996; 57: S53-S56
        • Ikizler T.A.
        • Pupim R.B.
        • Brouillette J.R.
        • et al.
        Hemodialysis stimulates muscle and whole-body protein loss and alters substrate oxidation.
        Am J Physiol Endocrinol Metab. 2002; 282: E107-E116
        • Ikizler T.A.
        Nutrition, inflammation and chronic kidney disease.
        Curr Opin Nephrol Hypertens. 2008; 17: 162-167
        • Nishimoto N.
        • Kishimoto T.
        Interleukin 6: from bench to bedside.
        Nat Clin Pract Rheumatol. 2006; 2: 619-626
        • Kalantar-Zadeh K.
        • Block G.
        • McAllister C.J.
        • Humphreys M.H.
        • Kopple J.D.
        Appetite and inflammation, nutrition, anemia, and clinical outcome in hemodialysis patients.
        Am J Clin Nutr. 2004; 80: 299-307
        • DeBoer M.D.
        • Scarlett J.M.
        • Levasseur P.R.
        • Grant W.F.
        • Marks D.L.
        Administration of IL-1β to the 4th ventricle causes anorexia that is blocked by agouti-related peptide and that coincides with activation of tyrosine-hydroxylase neurons in the nucleus of the solitary tract.
        Peptides. 2009; 30: 210-218
        • Lecker S.H.
        • Goldberg A.L.
        • Mitch W.E.
        Protein degradation by the ubiquitin-proteasome pathway in normal and disease States.
        J Am Soc Nephrol. 2006; 17: 1807-1819
        • Deger S.M.
        • Sundell M.B.
        • Siew E.D.
        • et al.
        Insulin resistance and protein metabolism in chronic hemodialysis patients.
        J Ren Nutr. 2012 Nov 27; ([Epub ahead of print])
        • Siew E.D.
        • Ikizler T.A.
        Determinants of insulin resistance and its effects on protein metabolism in patients with advanced chronic kidney disease.
        Contrib Nephrol. 2008; 161: 138-144
        • Flakoll P.J.
        • Carlson M.
        • Cherrington A.C.
        Physiological Action of Insulin.
        in: Leroith D.T.S. Olefsky J. Diabetes Mellitus: A Fundamental and Clinical Text. 2nd ed. Williams & Wilkins, Philadelphia, PA2000: 148-161
        • Wang X.
        • Hu Z.
        • Hu J.
        • Du J.
        • Mitch W.E.
        Insulin resistance accelerates muscle protein degradation: activation of the ubiquitin-proteasome pathway by defects in muscle cell signaling.
        Endocrinology. 2006; 147: 4160-4168
        • Pupim L.B.
        • Flakoll P.J.
        • Majchrzak K.M.
        • Aftab Guy D.L.
        • Stenvinkel P.
        • Ikizler T.A.
        Increased muscle protein breakdown in chronic hemodialysis patients with type 2 diabetes mellitus.
        Kidney Int. 2005; 68: 1857-1865
        • Pupim L.B.
        • Heimburger O.
        • Qureshi A.R.
        • Ikizler T.A.
        • Stenvinkel P.
        Accelerated lean body mass loss in incident chronic dialysis patients with diabetes mellitus.
        Kidney Int. 2005; 68: 2368-2374
        • Siew E.D.
        • Pupim L.B.
        • Majchrzak K.M.
        • Shintani A.
        • Flakoll P.J.
        • Ikizler T.A.
        Insulin resistance is associated with skeletal muscle protein breakdown in non-diabetic chronic hemodialysis patients.
        Kidney Int. 2007; 71: 146-152
        • Bailey J.L.
        • Wang X.
        • England B.K.
        • Price S.R.
        • Ding X.
        • Mitch W.E.
        The acidosis of chronic renal failure activates muscle proteolysis in rats by augmenting transcription of genes encoding proteins of the ATP-dependent ubiquitin-proteasome pathway.
        J Clin Invest. 1996; 97: 1447-1453
        • Graham K.A.
        • Reaich D.
        • Channon S.M.
        • Downie S.
        • Goodship T.H.J.
        Correction of acidosis in hemodialysis decreases whole body protein degradation.
        J Am Soc Nephrol. 1997; 8: 632-637
        • de Brito-Ashurst I.
        • Varagunam M.
        • Raftery M.J.
        • Yaqoob M.M.
        Bicarbonate supplementation slows progression of CKD and improves nutritional status.
        J Am Soc Nephrol. 2009; 20: 2075-2084
        • Wu D.Y.
        • Shinaberger C.S.
        • Regidor D.L.
        • McAllister C.J.
        • Kopple J.D.
        • Kalantar-Zadeh K.
        Association between serum bicarbonate and death in hemodialysis patients: is it better to be acidotic or alkalotic?.
        Clin J Am Soc Nephrol. 2006; 1: 70-78
        • Tonshoff B.
        • Schaefer F.
        • Mehls O.
        Disturbance of growth hormone-insulin-like growth factor axis in uraemia. Implications for recombinant human growth hormone treatment.
        Pediatr Nephrol. 1990; 4: 654-662
        • Kopple J.D.
        National kidney foundation K/DOQI clinical practice guidelines for nutrition in chronic renal failure.
        Am J Kidney Dis. 2001; 37: S66-S70
        • Kovesdy C.P.
        • Shinaberger C.S.
        • Kalantar-Zadeh K.
        Epidemiology of dietary nutrient intake in ESRD.
        Semin Dial. 2010; 23: 353-358
        • Shinaberger C.S.
        • Greenland S.
        • Kopple J.D.
        • et al.
        Is controlling phosphorus by decreasing dietary protein intake beneficial or harmful in persons with chronic kidney disease?.
        Am J Clin Nutr. 2008; 88: 1511-1518
        • Pupim L.B.
        • Majchrzak K.M.
        • Flakoll P.J.
        • Ikizler T.A.
        Intradialytic oral nutrition improves protein homeostasis in chronic hemodialysis patients with deranged nutritional status.
        J Am Soc Nephrol. 2006; 17: 3149-3157
        • Stratton R.J.
        • Bircher G.
        • Fouque D.
        • et al.
        Multinutrient oral supplements and tube feeding in maintenance dialysis: a systematic review and meta-analysis.
        Am J Kidney Dis. 2005; 46: 387-405
        • Caglar K.
        • Fedje L.
        • Dimmitt R.
        • Hakim R.M.
        • Shyr Y.
        • Ikizler T.A.
        Therapeutic effects of oral nutritional supplementation during hemodialysis.
        Kidney Int. 2002; 62: 1054-1059
        • Barakat M.M.
        • Nawab Z.M.
        • Yu A.W.
        • Lau A.H.
        • Ing T.S.
        • Daugirdas J.T.
        Hemodynamic effects of intradialytic food ingestion and the effects of caffeine.
        J Am Soc Nephrol. 1993; 3: 1813-1818
        • Pupim L.B.
        • Flakoll P.J.
        • Brouillette J.R.
        • Levenhagen D.K.
        • Hakim R.M.
        • Ikizler T.A.
        Intradialytic parenteral nutrition improves protein and energy homeostasis in chronic hemodialysis patients.
        J Clin Invest. 2002; 110: 483-492
        • Ericsson F.
        • Filho J.C.
        • Lindgren B.F.
        Growth hormone treatment in hemodialysis patients–a randomized, double-blind, placebo-controlled study.
        Scand J Urol Nephrol. 2004; 38: 340-347
        • Ikizler T.A.
        • Wingard R.L.
        • Breyer J.A.
        • Schulman G.
        • Parker R.A.
        • Hakim R.M.
        Short-term effects of recombinant human growth hormone in CAPD patients.
        Kidney Int. 1994; 46: 1178-1183
        • Johannsson G.
        • Bengtsson B.A.
        • Ahlmen J.
        Double-blind, placebo-controlled study of growth hormone treatment in elderly patients undergoing chronic hemodialysis: anabolic effect and functional improvement.
        Am J Kidney Dis. 1999; 33: 709-717
        • Feldt-Rasmussen B.
        • Lange M.
        • Sulowicz W.
        • et al.
        Growth hormone treatment during hemodialysis in a randomized trial improves nutrition, quality of life, and cardiovascular risk.
        J Am Soc Nephrol. 2007; 18: 2161-2171
        • Kopple J.D.
        • Cheung A.K.
        • Christiansen J.S.
        • et al.
        OPPORTUNITY™: a large-scale randomized clinical trial of growth hormone in hemodialysis patients.
        Nephrol Dial Transplant. 2011; 26: 4095-4103
        • Yeh S.
        • Wu S.Y.
        • Levine D.M.
        • et al.
        Quality of life and stimulation of weight gain after treatment with megestrol acetate: correlation between cytokine levels and nutritional status, appetite in geriatric patients with wasting syndrome.
        J Nutr Health Aging. 2000; 4: 246-251
        • Johansen K.L.
        • Painter P.L.
        • Sakkas G.K.
        • Gordon P.
        • Doyle J.
        • Shubert T.
        Effects of resistance exercise training and nandrolone decanoate on body composition and muscle function among patients who receive hemodialysis: a randomized, controlled trial.
        J Am Soc Nephrol. 2006; 17: 2307-2314
        • Pupim L.B.
        • Flakoll P.J.
        • Levenhagen D.K.
        • Ikizler T.A.
        Exercise augments the acute anabolic effects of intradialytic parenteral nutrition in chronic hemodialysis patients.
        Am J Physiol Endocrinol Metab. 2004; 286: E589-E597
        • Dong J.
        • Sundell M.B.
        • Pupim L.B.
        • Wu P.
        • Shintani A.
        • Ikizler T.A.
        The effect of resistance exercise to augment long-term benefits of intradialytic oral nutritional supplementation in chronic hemodialysis patients.
        J Ren Nutr. 2011; 21: 149-159
        • Kopple J.D.
        • Wang H.
        • Casaburi R.
        • et al.
        Exercise in maintenance hemodialysis patients induces transcriptional changes in genes favoring anabolic muscle.
        J Am Soc Nephrol. 2007; 18: 2975-2986
        • Collins A.J.
        • Foley R.N.
        • Chavers B.
        • et al.
        'United States Renal Data System 2011 Annual Data Report: Atlas of chronic kidney disease & end-stage renal disease in the United States.
        Am J Kidney Dis. 2012; 59: e1-e420
        • Kalantar-Zadeh K.
        • Abbott K.C.
        • Salahudeen A.K.
        • Kilpatrick R.D.
        • Horwich T.B.
        Survival advantages of obesity in dialysis patients.
        Am J Clin Nutr. 2005; 81: 543-554
        • Biolo G.
        • Ciocchi B.
        • Bosutti A.
        • Situlin R.
        • Toigo G.
        • Guarnieri G.
        Pentoxifylline acutely reduces protein catabolism in chronically uremic patients.
        Am J Kidney Dis. 2002; 40: 1162-1172
        • Himmelfarb J.
        • Phinney S.
        • Ikizler T.A.
        • Kane J.
        • McMonagle E.
        • Miller G.
        Gamma-tocopherol and docosahexaenoic acid decrease inflammation in dialysis patients.
        J Ren Nutr. 2007; 17: 296-304
        • Hung A.M.
        • Ellis C.D.
        • Shintani A.
        • Booker C.
        • Ikizler T.A.
        IL-1beta receptor antagonist reduces inflammation in hemodialysis patients.
        J Am Soc Nephrol. 2011; 22: 437-442
        • Pupim L.B.
        • Cuppari L.
        • Ikizler T.A.
        Nutrition and metabolism in kidney disease.
        Semin Nephrol. 2006; 26: 134-157